LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. INTC
2. SPCX
3. DSX
4. GNK
5. DAL
6. AWK
7. MDA
8. ACN
9. III
10. SAN

Go back to LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis
(NASDAQ: DNTH) Delayed: 82.49 +0.60 (0.73%)
Previous Close $81.89    52 Week High $ 
Open $83.64    52 Week Low $ 
Day High $85.00    P/E N/A 
Day Low $79.79    EPS $ 
Volume 2,478,108